NCT05490173View on ClinicalTrials.gov

The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

May 22, 2026

Study Completion Date

December 28, 2026

Conditions
Premature BirthExtreme PrematurityPreterm Intraventricular HemorrhageHypoxia-Ischemia, CerebralNeurodevelopmental Disorders
Interventions
OTHER

Exosomes derived from mesenchymal stromal cells (MSCs)

Exosomes derived from mesenchymal stromal cells (MSCs) will be administered intranasal in ELBW infants

Trial Locations (1)

117997

Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare, Moscow

All Listed Sponsors
lead

Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare

OTHER_GOV

NCT05490173 - The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants | Biotech Hunter | Biotech Hunter